Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease

Lu Zhang, MD, Ai-lin Zhao, MD, Jun Feng, MD, Xinxin Cao, MD, Yan Zhang, MD, Tienan Zhu, MD, Minghui Duan, MD, Daobin Zhou, MD, Jian Li, MD

Blood (2018) 132 (Supplement 1): 4142.

https://doi.org/10.1182/blood-2018-99-113528

Published: 2018

Journal Articles

Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects.

Yongqiang Zhao, MD, Xuefeng Wang, MD, Qiulan Ding, MD, Xuqian Wei, MD, Tienan Zhu, MD, Florentia Kaguelidou, MD, Renchi Yang, MD, Changgeng Ruan, MD, Zhaoyue Wang, MD, Xia Bai, MD, Nicole Schlegel, MD

Blood (2007) 110 (11): 3982.

https://doi.org/10.1182/blood.V110.11.3982.3982

Published: 2007

Journal Articles

Treatment of Primary Central Nervous System Lymphoma with a Combination of Intraventricular Administration of Rituximab and Systemic Chemotherapy.

Shujie Wang, MD, PhD, Wei Zhang, MD, Wei Lian, MD, Yongji Wu, MD, Nong Zou, MD, Tienan Zhu, MD, Daobin Zhou, MD, Ying Xu, MD, Ti Shen, MD, Yongqiang Zhao, MD, PhD

Blood (2006) 108 (11): 4695.

https://doi.org/10.1182/blood.V108.11.4695.4695

Published: 2006

Journal Articles

Multiple Cycles of Recombinant Human Thrombopoietin Therapy in a Patient with Chronic Refractory Idiopathic Thrombocytopenic Purpura.

Yongqiang Zhao, MD, Baolai Hua, MD, Nong Zou, MD, Shujie Wang, MD, Tienan Zhu, MD

Blood (2004) 104 (11): 3933.

https://doi.org/10.1182/blood.V104.11.3933.3933

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease

Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects.

Treatment of Primary Central Nervous System Lymphoma with a Combination of Intraventricular Administration of Rituximab and Systemic Chemotherapy.

Multiple Cycles of Recombinant Human Thrombopoietin Therapy in a Patient with Chronic Refractory Idiopathic Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

Update search

A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease

Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects.

Treatment of Primary Central Nervous System Lymphoma with a Combination of Intraventricular Administration of Rituximab and Systemic Chemotherapy.

Multiple Cycles of Recombinant Human Thrombopoietin Therapy in a Patient with Chronic Refractory Idiopathic Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only